NASDAQ · Financial Statements
NRX Pharmaceuticals, Inc. (NRXP) Financial Statements
$2.85
NASDAQ: NRXP
Market Cap $123.39M
Overview Financials Dividend NRX Pharmaceuticals, Inc. most recently reported annual revenue of $1.0M, net profit of $-29.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $1.0M Operating Profit $-95.0M $-44.0M $-28.0M $-20.0M $-16.0M Net Profit $-93.0M $-40.0M $-30.0M $-25.0M $-29.0M EPS $-7.44 $-0.60 $-3.98 $-2.39 $-1.34 Op Margin — — — — -1324.4%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $33.0M $26.0M $7.0M $4.0M $13.0M Total Liabilities $12.0M $18.0M $19.0M $27.0M $29.0M Cash $28.0M $20.0M $5.0M $1.0M $8.0M Borrowings $1.0M $11.0M $9.0M $7.0M $1.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-38.0M $-40.0M $-22.0M $-11.0M $-14.0M Investing Cash Flow $0 $0 $0 $0 $-3.0M Financing Cash Flow $10.0M $0 $0 $3.0M $0 Net Cash Flow $26.0M $-8.0M $-15.0M $-3.0M $6.0M Free Cash Flow $-38.0M $-40.0M $-22.0M $-11.0M $-14.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.03 EV / EBITDA -4.40 FCF Yield -16.95% Quick Ratio 0.86 Interest Coverage -17.45 Return 1Y 42.12% Return 3Y 19.46% Return 5Y -94.81%
Screens featuring this stock